401(k) · DOL Form 5500 · 2023

Recursion Pharmaceuticals Inc. 401(k) Plan

Data updated 2026-08-25

$40M
Total assets Below avg plan size
467
Participants Below avg headcount
83rd
Percentile by assets National rank
$86,244
Avg per participant Below avg balance/head
PlainRetire home → About this data RSS: change history

Official DOL plan name: Recursion Pharmaceuticals 401(k) Plan · Sponsored by Recursion Pharmaceuticals Inc. · Utah · Professional & Technical Services

$40M in assets, 467 participants

Recursion Pharmaceuticals Inc.'s Recursion Pharmaceuticals 401(k) Plan reported $40M in total assets and 467 participants in its 2023 DOL Form 5500 filing, ranking in the 83rd percentile by assets among filed plans. Figures are as reported by the plan sponsor to the Department of Labor, not audited or endorsed by PlainRetire.

  • #17,040 in Professional & Technical Services (20,321 peers)

Where Recursion Pharmaceuticals 401(k) Plan sits by assets

Recursion Pharmaceuticals 401(k) Plan sits in the top quartile of all filed plans by assets, $40M for 467 participants (~$86,244/participant), up 65.7% in 2023.

#17,040
in Professional & Technical Services (20,321 peers)
+65.7%
assets growth YoY
0.4×
vs typical plan assets (national mean)

Recursion Pharmaceuticals 401(k) Plan's outsized position by total assets

Recursion Pharmaceuticals 401(k) Plan vs every filed plan by assets

End-of-year total assets · plan year 2023 · DOL Form 5500

$40,275,815 Top 17% higher than 83% of 127,068 filed plans

This plan $0 $2,050,000,000 every filed plan with reported assets, bucketed by value

Dashed line + filled bar = this entry, among filed plans.

Source U.S. Department of Labor Form 5500 filings (EBSA) · plan year 2023

Recursion Pharmaceuticals 401(k) Plan among mid-size filed plans by headcount

Plan-year 2023 Form 5500 filings with a reported participant count, partitioned by headcount band, not by assets. Recursion Pharmaceuticals 401(k) Plan sits mid-pack in the medium band (467 participants).

What changed between DOL Form 5500 filings

plan year 2022 → plan year 2023

  • Recursion Pharmaceuticals 401(k) Plan reported net income rose from $4M in the plan year 2022 filing to $16M in the plan year 2023 filing.
  • Recursion Pharmaceuticals 401(k) Plan end-of-year assets rose from $24M in the plan year 2022 filing to $40M in the plan year 2023 filing.
  • Recursion Pharmaceuticals 401(k) Plan reported participants rose from 384 in the plan year 2022 filing to 467 in the plan year 2023 filing.

See the national 2022→2023 release diff →

DOL schedule card

Filing strip 464099738 · Recursion Pharmaceuticals Inc. PY 2023 · 401(k)

Recursion Pharmaceuticals 401(k) Plan · $40M · 467 · 83rd

  • VS-ST $40M
  • VS-ST 467
  • VS-ST 83rd
  • VS-ST 401(k)
  • VS-ST near Eye Consultants of Atlanta, P.C. Profit Sharing Plan and Trust
  • VS-ST ind #17040

Stamps derive from this plan's Form 5500 line items (assets, participants, type, EIN, cohort placement) - not a quality rating of the sponsor. Read with Professional & Technical Services retirement plans → · Plans in Utah →

Recursion Pharmaceuticals 401(k) Plan in the asset neighbourhood

Bigge Crane and Rigging Co. 401(k) ProfitBigge Crane and Rigging Co. …$40MRvo Health 401(k) Retirement PlanRvo Health 401(k) Retirement…$40MRecursion Pharmaceuticals 401(k) PlanRecursion Pharmaceuticals 40…$40MEye Consultants of Atlanta, P.C. Profit Sharing Plan and TrustEye Consultants of Atlanta, …$40MResco Products, Inc. 401(k) & Profit Sharing PlanResco Products, Inc. 401(k) …$40M
End-of-year total assets ($M) among Recursion Pharmaceuticals 401(k) Plan and nearest nationwide 401(k) peers. Source: DOL Form 5500 plan year 2023.

Scale-class filing particulars (2023)

Total Assets (Beginning of Year)$24M
Net Assets (End of Year)$40M
Net Income$16M
Employer EIN464099738
Plan Effective Date2016-01-01
Filing StatusFILING RECEIVED

Sponsor Plan History (Recursion Pharmaceuticals Inc.)

Sponsor-wide plan assets over time

All Recursion Pharmaceuticals Inc. plans reported in each filing year

Latest sponsor-wide plan assets
$54M 121.45640815515503% vs 2022
2024 filing year
$20M$30M$40M$50M$60M 202220232024 $24.3M $53.8M ▲ +121.4%
Year Plans Participants Total Assets
2022 1 384 $24M
2023 1 467 $40M
2024 1 431 $54M

Nearby 401(k) Plans in Utah

Peer 401(k) plans, same state, same plan type, ranked by total assets.

Recursion Pharmaceuticals 401(k) Plan vs. nearby 401(k) plans in Utah, assets vs. participants Scatter plot of 6 data points. -200000200004000060000 -202468 Total assets ($B) Participants Recursion Pharmaceuticals 401(k) Plan, Total assets ($B): 0.040275815 · Participants: 467Recursion Pharmaceuticals 401(k) PlanIntermountain Healthcare Savings Plus 401(k) Plan, Total assets ($B): 6.015479 · Participants: 46680Intermountain Healthcare Savings Plus 401(k) PlanDeseret 401(k) Plan, Total assets ($B): 5.481729272 · Participants: 24292Deseret 401(k) PlanZions Bancorporation, N.a. Payshelter 401(k) and Employee Stock Ownership Plan, Total assets ($B): 1.662904822 · Participants: 10088Zions Bancorporation, N.a. Payshelter 401(k) and Employee Stock Ownership PlanSkywest, Inc. Employees' Retirement Plan, Total assets ($B): 1.192769515 · Participants: 15411Skywest, Inc. Employees' Retirement PlanAutoliv Asp, Inc. Employee Savings and Investment Plan, Total assets ($B): 0.633594695 · Participants: 4537Autoliv Asp, Inc. Employee Savings and Investment Plan
Recursion Pharmaceuticals 401(k) Plan vs. nearby 401(k) plans in Utah, assets vs. participants
Compare Recursion Pharmaceuticals 401(k) Plan side-by-side with 3 peers →

Recursion Pharmaceuticals 401(k) Plan's out-of-state 401(k) peers by assets and headcount

Outside Utah, the nearest 401(k) by assets is Eye Consultants of Atlanta, P.C. Profit Sharing Plan and Trust in GA ($40M); by covered participants it is United Fashions of Texas 401(k) Plan in TX (467 participants). Same-state nearby plans are listed separately above.

Similar participant headcount

Nearest other-state filings by covered participants (467 participants); asset peers above are excluded.

DOL Form 5500 plan year 2023. Asset totals can differ widely at the same headcount; neither axis is a quality rating.

Frequently Asked Questions

How did Recursion Pharmaceuticals 401(k) Plan assets move in 2023? ▼
Recursion Pharmaceuticals 401(k) Plan surged - up 65.7% during 2023, from $24M to $40M. Reported net income was $16M.
How have Recursion Pharmaceuticals Inc. plan assets changed over time? ▼
Across 3 plan years on file (2022-2024), Recursion Pharmaceuticals Inc.'s sponsor-wide assets grew 121.5%, from $24M to $54M.
Where does Recursion Pharmaceuticals 401(k) Plan rank by assets among Form 5500 filers? ▼
Recursion Pharmaceuticals 401(k) Plan ranks in the 83rd percentile by end-of-year assets among 127,072 plans that reported assets for plan year 2023 (in the top quartile of all filed plans by assets).
Which 401(k) plans are similar in size to Recursion Pharmaceuticals 401(k) Plan? ▼
Among 401(k) plans in other states, the closest by assets is Eye Consultants of Atlanta, P.C. Profit Sharing Plan and Trust in GA ($40M, 210 participants).
Which 401(k) plans cover a similar participant headcount to Recursion Pharmaceuticals 401(k) Plan? ▼
Among 401(k) plans in other states, the closest by covered participants is United Fashions of Texas 401(k) Plan in TX (467 participants, $9M in assets).

Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2023.

Source: DOL EFAST2 filing system (efast.dol.gov) - original filing retrieval by EIN 464099738.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from U.S. Department of Labor Form 5500 filings (EBSA). See our methodology for details.